Median infectious dose of human norovirus GII.4 in gnotobiotic pigs is decreased by simvastatin treatment and increased by age

Journal of General Virology

Volumn 94, Issue PART9, 2013, Pages 2005-2016

  Bui, Tammy ^a   Kocher, Jacob ^a   Li, Yanru ^a   Wen, Ke ^a   Li, Guohua ^a   Liu, Fangning ^a   Yang, Xingdong ^a   Leroith, Tanya ^a   Tan, Ming ^b   Xia, Ming ^b   Zhong, Weiming ^b   Jiang, Xi ^b   Yuan, Lijuan ^a  

^a VIRGINIA MARYLAND REGIONAL COLLEGE OF VETERINARY MEDICINE   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; SIMVASTATIN; VIRUS ANTIGEN; VIRUS RNA;

AGE DISTRIBUTION; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOPATHOLOGY; DUODENUM; EXPERIMENTAL PIG; FEMALE; GENETIC VARIABILITY; GENOTYPE; GNOTOBIOTICS; INFECTION SENSITIVITY; MICROVILLUS; NEWBORN; NONHUMAN; NOROVIRUS; NOROVIRUS INFECTION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SMALL INTESTINE; VIRUS LOAD; VIRUS SHEDDING;

AGE FACTORS; ANIMALS; CALICIVIRIDAE INFECTIONS; DISEASE MODELS, ANIMAL; DISEASE SUSCEPTIBILITY; GENOTYPE; GERM-FREE LIFE; HUMANS; HYPOLIPIDEMIC AGENTS; INTESTINES; MOLECULAR SEQUENCE DATA; NOROVIRUS; RNA, VIRAL; SEQUENCE ANALYSIS, DNA; SIMVASTATIN; SWINE; VIRAL LOAD;

EID: 84881628471     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.054080-0     Document Type: Article

References (53)

1. Armstrong, W. D. & Cline, T. R. (1977). Effects of various nutrient levels and enviromental temperatures on the incidence of colibacillary diarrhea in pigs: intestinal fistulation and titration studies. J Anim Sci 45, 1042-1050.
2. Atmar, R. L., Opekun, A. R., Gilger, M. A., Estes, M. K., Crawford, S. E., Neill, F. H. & Graham, D. Y. (2008). Norwalk virus shedding after experimental human infection. Emerg Infect Dis 14, 1553-1557.
3. Atmar, R. L., Bernstein, D. I., Harro, C. D., Al-Ibrahim, M. S., Chen, W. H., Ferreira, J., Estes, M. K., Graham, D. Y., Opekun, A. R. & other authors (2011). Norovirus vaccine against experimental human Norwalk virus illness. N Engl J Med 365, 2178-2187.
4. Beersma, M. F., Schutten, M., Vennema, H., Hartwig, N. G., Mes, T. H., Osterhaus, A. D., van Doornum, G. J. & Koopmans, M. (2009). Norovirus in a Dutch tertiary care hospital (2002-2007): frequent nosocomial transmission and dominance of GIIb strains in young children. J Hosp Infect 71, 199-205.
5. Bok, K., Parra, G. I., Mitra, T., Abente, E., Shaver, C. K., Boon, D., Engle, R., Yu, C., Kapikian, A. Z. & other authors (2011). Chimpanzees as an animal model for human norovirus infection and vaccine development. Proc Natl Acad Sci U S A 108, 325-330.
6. Brito, L. A. & Singh, M. (2011). Acceptable levels of endotoxin in vaccine formulations during preclinical research. J Pharm Sci 100, 34-37.
7. Busch, J., Specht, S., Ezzelarab, M. & Cooper, D. K. (2006). Buccal mucosal cell immunohistochemistry: a simple method of determining the ABH phenotype of baboons, monkeys, and pigs. Xenotransplantation 13, 63-68.
8. Chang, K. O. (2009). Role of cholesterol pathways in norovirus replication. J Virol 83, 8587-8595.
9. Cheetham, S., Souza, M., Meulia, T., Grimes, S., Han, M. G. & Saif, L. J. (2006). Pathogenesis of a genogroup II human norovirus in gnotobiotic pigs. J Virol 80, 10372-10381.
10. Cheetham, S., Souza, M., McGregor, R., Meulia, T., Wang, Q. & Saif, L. J. (2007). Binding patterns of human norovirus-like particles to buccal and intestinal tissues of gnotobiotic pigs in relation to A/H histo-blood group antigen expression. J Virol 81, 3535-3544.
11. El-Kamary, S. S., Pasetti, M. F., Mendelman, P. M., Frey, S. E., Bernstein, D. I., Treanor, J. J., Ferreira, J., Chen, W. H., Sublett, R. & other authors (2010). Adjuvanted intranasal Norwalk virus-like particle vaccine elicits antibodies and antibody-secreting cells that express homing receptors for mucosal and peripheral lymphoid tissues. J Infect Dis 202, 1649-1658.
12. Farkas, T., Zhong, W. M., Jing, Y., Huang, P. W., Espinosa, S. M., Martinez, N., Morrow, A. L., Ruiz-Palacios, G. M., Pickering, L. K. & Jiang, X. (2004). Genetic diversity among sapoviruses. Arch Virol 149, 1309-1323.
13. Gallimore, C. I., Cubitt, D., du Plessis, N. & Gray, J. J. (2004). Asymptomatic and symptomatic excretion of noroviruses during a hospital outbreak of gastroenteritis. J Clin Microbiol 42, 2271-2274.
14. Günther, H., Otto, P. & Heilmann, P. (1984). [Diarrhea in young calves. 6. Determination of the pathogenicity of a bovine coronavirus and an unidentified icosahedral virus]. Arch Exp Veterinarmed 38, 781-792 (in German).
15. Guo, L., Wang, J., Zhou, H., Si, H., Wang, M., Song, J., Han, B., Shu, Y., Ren, L. & other authors (2008). Intranasal administration of a recombinant adenovirus expressing the norovirus capsid protein stimulates specific humoral, mucosal, and cellular immune responses in mice. Vaccine 26, 460-468.
16. Harris, J. P., Edmunds, W. J., Pebody, R., Brown, D. W. & Lopman, B. A. (2008). Deaths from norovirus among the elderly, England and Wales. Emerg Infect Dis 14, 1546-1552.
17. Huang, P., Farkas, T., Marionneau, S., Zhong, W., Ruvoen-Clouet, N., Morrow, A. L., Altaye, M., Pickering, L. K., Newburg, D. S. & other authors (2003). Noroviruses bind to human ABO, Lewis, and secretor histo-blood group antigens: identification of 4 distinct strainspecific patterns. J Infect Dis 188, 19-31.
18. Huang, P., Farkas, T., Zhong, W., Tan, M., Thornton, S., Morrow, A. L. & Jiang, X. (2005). Norovirus and histo-blood group antigens: demonstration of a wide spectrum of strain specificities and classification of two major binding groups among multiple binding patterns. J Virol 79, 6714-6722.
19. Hutson, A. M., Atmar, R. L., Graham, D. Y. & Estes, M. K. (2002). Norwalk virus infection and disease is associated with ABO histoblood group type. J Infect Dis 185, 1335-1337.
20. Jiang, X., Huang, P. W., Zhong, W. M., Farkas, T., Cubitt, D. W. & Matson, D. O. (1999). Design and evaluation of a primer pair that detects both Norwalk- and Sapporo-like caliciviruses by RT-PCR. J Virol Methods 83, 145-154.
21. Jung, K., Wang, Q., Kim, Y., Scheuer, K., Zhang, Z., Shen, Q., Chang, K. O. & Saif, L. J. (2012). The effects of simvastatin or interferon-a on infectivity of human norovirus using a gnotobiotic pig model for the study of antivirals. PLoS ONE 7, e41619.
22. Kageyama, T., Kojima, S., Shinohara, M., Uchida, K., Fukushi, S., Hoshino, F. B., Takeda, N. & Katayama, K. (2003). Broadly reactive and highly sensitive assay for Norwalk-like viruses based on real-time quantitative reverse transcription-PCR. J Clin Microbiol 41, 1548-1557.
23. Karst, S. M. (2010). Pathogenesis of noroviruses, emerging RNA viruses. Viruses 2, 748-781.
24. Karst, S. M., Wobus, C. E., Lay, M., Davidson, J. & Virgin, H. W., IV (2003). STAT1-dependent innate immunity to a Norwalk-like virus. Science 299, 1575-1578.
25. Koo, H. L., Ajami, N., Atmar, R. L. & DuPont, H. L. (2010). Noroviruses: the leading cause of gastroenteritis worldwide. Discov Med 10, 61-70.
26. Lay, M. K., Atmar, R. L., Guix, S., Bharadwaj, U., He, H., Neill, F. H., Sastry, K. J., Yao, Q. & Estes, M. K. (2010). Norwalk virus does not replicate in human macrophages or dendritic cells derived from the peripheral blood of susceptible humans. Virology 406, 1-11.
27. Lindesmith, L., Moe, C., Lependu, J., Frelinger, J. A., Treanor, J. & Baric, R. S. (2005). Cellular and humoral immunity following Snow Mountain virus challenge. J Virol 79, 2900-2909.
28. LoBue, A. D., Lindesmith, L., Yount, B., Harrington, P. R., Thompson, J. M., Johnston, R. E., Moe, C. L. & Baric, R. S. (2006). Multivalent norovirus vaccines induce strong mucosal and systemic blocking antibodies against multiple strains. Vaccine 24, 5220-5234.
29. LoBue, A. D., Thompson, J. M., Lindesmith, L., Johnston, R. E. & Baric, R. S. (2009). Alphavirus-adjuvanted norovirus-like particle vaccines: heterologous, humoral, and mucosal immune responses protect against murine norovirus challenge. J Virol 83, 3212-3227.
30. Mach, F. (2002). Immunosuppressive effects of statins. Atheroscler Suppl 3, 17-20.
31. Marionneau, S., Ruvoën, N., Le Moullac-Vaidye, B., Clement, M., Cailleau-Thomas, A., Ruiz-Palacois, G., Huang, P., Jiang, X. & Le Pendu, J. (2002). Norwalk virus binds to histo-blood group antigens present on gastroduodenal epithelial cells of secretor individuals. Gastroenterology 122, 1967-1977.
32. Meyer, R. C., Bohl, E. H. & Kohler, E. M. (1964). Procurement and maintenance of germ-free swine for microbiological investigations. Appl Microbiol 12, 295-300.
33. Otto, P. H., Clarke, I. N., Lambden, P. R., Salim, O., Reetz, J. & Liebler-Tenorio, E. M. (2011). Infection of calves with bovine norovirus GIII.1 strain Jena virus: an experimental model to study the pathogenesis of norovirus infection. J Virol 85, 12013-12021.
34. Reed, L. & Muench, H. (1938). A simple method of estimating fifty percent endpoints. Am J Hyg 27, 493-497.
35. Rockx, B. H., Bogers, W. M., Heeney, J. L., van Amerongen, G. & Koopmans, M. P. (2005a). Experimental norovirus infections in nonhuman primates. J Med Virol 75, 313-320.
36. Rockx, B. H., Vennema, H., Hoebe, C. J., Duizer, E. & Koopmans, M. P. (2005b). Association of histo-blood group antigens and susceptibility to norovirus infections. J Infect Dis 191, 749-754.
37. Souza, M., Cheetham, S. M., Azevedo, M. S., Costantini, V. & Saif, L. J. (2007a). Cytokine and antibody responses in gnotobiotic pigs after infection with human norovirus genogroup II.4 (HS66 strain). J Virol 81, 9183-9192.
38. Souza, M., Costantini, V., Azevedo, M. S. & Saif, L. J. (2007b). A human norovirus-like particle vaccine adjuvanted with ISCOM or mLT induces cytokine and antibody responses and protection to the homologous GII.4 human norovirus in a gnotobiotic pig disease model. Vaccine 25, 8448-8459.
39. Souza, M., Azevedo, M. S., Jung, K., Cheetham, S. & Saif, L. J. (2008). Pathogenesis and immune responses in gnotobiotic calves after infection with the genogroup II.4-HS66 strain of human norovirus. J Virol 82, 1777-1786.
40. Subekti, D. S., Tjaniadi, P., Lesmana, M., McArdle, J., Iskandriati, D., Budiarsa, I. N., Walujo, P., Suparto, I. H., Winoto, I. & other authors (2002). Experimental infection of Macaca nemestrina with a Toronto Norwalk-like virus of epidemic viral gastroenteritis. J Med Virol 66, 400-406.
41. Sugieda, M., Nagaoka, H., Kakishima, Y., Ohshita, T., Nakamura, S. & Nakajima, S. (1998). Detection of Norwalk-like virus genes in the caecum contents of pigs. Arch Virol 143, 1215-1221.
42. Takanashi, S., Wang, Q., Chen, N., Shen, Q., Jung, K., Zhang, Z., Yokoyama, M., Lindesmith, L. C., Baric, R. S. & Saif, L. J. (2011). Characterization of emerging GII.g/GII.12 noroviruses from a gastroenteritis outbreak in the United States in 2010. J Clin Microbiol 49, 3234-3244.
43. Tan, M. & Jiang, X. (2005). Norovirus and its histo-blood group antigen receptors: an answer to a historical puzzle. Trends Microbiol 13, 285-293.
44. Tan, M. & Jiang, X. (2011). Norovirus-host interaction: multiselections by human histo-blood group antigens. Trends Microbiol 19, 382-388.
45. Tan, M., Fang, P., Chachiyo, T., Xia, M., Huang, P., Fang, Z., Jiang, W. & Jiang, X. (2008). Noroviral P particle: structure, function and applications in virus-host interaction. Virology 382, 115-123.
46. Tian, P., Jiang, X., Zhong, W., Jensen, H. M., Brandl, M., Bates, A. H., Engelbrektson, A. L. & Mandrell, R. (2007). Binding of recombinant norovirus like particle to histo-blood group antigen on cells in the lumen of pig duodenum. Res Vet Sci 83, 410-418.
47. Turcios-Ruiz, R. M., Axelrod, P., St John, K., Bullitt, E., Donahue, J., Robinson, N. & Friss, H. E. (2008). Outbreak of necrotizing enterocolitis caused by norovirus in a neonatal intensive care unit. J Pediatr 153, 339-344.
48. Velasquez, L. S., Shira, S., Berta, A. N., Kilbourne, J., Medi, B. M., Tizard, I., Ni, Y., Arntzen, C. J. & Herbst-Kralovetz, M. M. (2011). Intranasal delivery of Norwalk virus-like particles formulated in an in situ gelling, dry powder vaccine. Vaccine 29, 5221-5231.
49. Ward, J. M., Wobus, C. E., Thackray, L. B., Erexson, C. R., Faucette, L. J., Belliot, G., Barron, E. L., Sosnovtsev, S. V. & Green, K. Y. (2006). Pathology of immunodeficient mice with naturally occurring murine norovirus infection. Toxicol Pathol 34, 708-715.
50. Wobus, C. E., Thackray, L. B. & Virgin, H. W., IV (2006). Murine norovirus: a model system to study norovirus biology and pathogenesis. J Virol 80, 5104-5112.
51. Woode, G. N. & Bridger, J. C. (1978). Isolation of small viruses resembling astroviruses and caliciviruses from acute enteritis of calves. J Med Microbiol 11, 441-452.
52. Xia, M., Farkas, T. & Jiang, X. (2007). Norovirus capsid protein expressed in yeast forms virus-like particles and stimulates systemic and mucosal immunity in mice following an oral administration of raw yeast extracts. J Med Virol 79, 74-83.
53. Yang, Y., Xia, M., Tan, M., Huang, P., Zhong, W., Pang, X. L., Lee, B. E., Meller, J., Wang, T. & Jiang, X. (2010). Genetic and phenotypic characterization of GII-4 noroviruses that circulated during 1987 to 2008. J Virol 84, 9595-9607.